Forbes August 7, 2024
Bruce Japsen

Walgreens Boots Alliance may sell its entire stake in doctor-staffed clinic operator VillageMD, which has already cost the drugstore giant billions of dollars.

“The company is currently evaluating a variety of options with respect to VillageMD in light of ongoing investments by the company in VillageMD’s businesses and VillageMD’s substantial ongoing and expected future cash requirements,” Walgreens said in a filing Wednesday with the U.S. Securities and Exchange Commission. “These options could include a sale of all or part of the VillageMD businesses, possible restructuring options and other strategic opportunities.”

Walgreens chief executive officer Tim Wentworth, who took over as the company’s top executive last October, told analysts in June the company would remain an investor and partner, but is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Primary care, Provider, Trends
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article